Pancreatic Cancer Research

ResearcherNagoya City UniversityActive in the last 2 years

Hiromi Kataoka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9491-0723; OpenAlex author ID A5047369080. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. Osteopontin secreted from obese adipocytes enhances angiogenesis and promotes progression of pancreatic ductal adenocarcinoma in obesity. Last author DOI 10.1007/s13402-023-00865-y↗
  2. Concomitant Pancreatic Ductal Adenocarcinoma and Type 1 Autoimmune Pancreatitis: A Potential Issue in the Diagnosis of Carcinoma by Endoscopic Ultrasound-guide… Last author DOI 10.2169/internalmedicine.0075-22↗
  3. Class III β-Tubulin Expression Is of Value in Selecting nab -Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000002032↗
  4. Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer. Last author DOI 10.1111/cas.14689↗
  5. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-3021↗
  6. Metachronous Pancreatic Ductal Adenocarcinoma with Adjacent Serous Cystadenoma that Was Preoperatively Diagnosed by EUS-FNA: A Case Report and Review of the Li… Last author DOI 10.2169/internalmedicine.3912-19↗
  7. Maltotriose Conjugation to a Chlorin Derivative Enhances the Antitumor Effects of Photodynamic Therapy in Peritoneal Dissemination of Pancreatic Cancer. First author DOI 10.1158/1535-7163.mct-16-0670↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Itaru Naitoh · 5 shared papers, 2017–2023 · strength 0.55
  2. Yasuki Hori · 5 shared papers, 2017–2023 · strength 0.55
  3. Michihiro Yoshida · 5 shared papers, 2017–2023 · strength 0.55
  4. Akihisa Kato · 5 shared papers, 2017–2023 · strength 0.55
  5. Satoru Takahashi · 5 shared papers, 2017–2023 · strength 0.52
  6. Kenta Kachi · 3 shared papers, 2020–2023 · strength 0.37
  7. Yoichi Matsuo · 2 shared papers, 2020–2023 · strength 0.25
  8. Naruomi Jinno · 2 shared papers, 2020–2021 · strength 0.22
  9. Shigeki Fukusada · 1 shared paper, 2024 · strength 0.18
  10. Kenji Notohara · 1 shared paper, 2023 · strength 0.15
  11. Kenta Saito · 1 shared paper, 2023 · strength 0.15
  12. Hiroyuki Kato · 1 shared paper, 2022 · strength 0.12
  13. Tadahisa Inoue · 1 shared paper, 2022 · strength 0.12
  14. Yoshihiko Tasaki · 1 shared paper, 2021 · strength 0.10
  15. Wentao Gao · 1 shared paper, 2021 · strength 0.10
  16. Keiko Shinjo · 1 shared paper, 2021 · strength 0.10
  17. Kazunori Kataoka · 1 shared paper, 2021 · strength 0.10
  18. Chenjie Qiu · 1 shared paper, 2021 · strength 0.10
  19. Yutaka Kondo · 1 shared paper, 2021 · strength 0.10
  20. Takashi Joh · 1 shared paper, 2017 · strength 0.05
  21. Takashi Murakami · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.